Atypical Antipsychotic Agents
- PMID: 28846323
- Bookshelf ID: NBK448156
Atypical Antipsychotic Agents
Excerpt
This activity offers an exploration of atypical antipsychotics, the preferred pharmacological intervention for acute psychoses. Distinguished by their distinct clinical profile from conventional antipsychotics, atypical antipsychotics have emerged as frontline agents in managing psychosis. This program delineates their indications, mechanism of action, administration guidelines, potential adverse effects, contraindications, toxicology considerations, and monitoring protocols. By understanding atypical antipsychotics, healthcare practitioners gain the expertise to navigate treatment complexities adeptly, thus ensuring optimal patient care and minimizing adverse reactions. Through evidence-based insights, this initiative empowers healthcare professionals to cultivate interprofessional collaboration, fostering improved treatment outcomes and bolstering patient well-being in psychiatric disorders treated with atypical antipsychotics.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Shafiq S, Pringsheim T. Using antipsychotics for behavioral problems in children. Expert Opin Pharmacother. 2018 Sep;19(13):1475-1488. - PubMed
-
- Clissold M, Crowe SF. Comparing the effect of the subcategories of atypical antipsychotic medications on cognition in schizophrenia using a meta-analytic approach. J Clin Exp Neuropsychol. 2019 Feb;41(1):26-42. - PubMed
-
- Preda A, Shapiro BB. A safety evaluation of aripiprazole in the treatment of schizophrenia. Expert Opin Drug Saf. 2020 Dec;19(12):1529-1538. - PubMed
Publication types
LinkOut - more resources
Full Text Sources